The treatment of atrial fibrillation and flutter: a review.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000925:Anticoagulants / Q000627:therapeutic use; D001281:Atrial Fibrillation / Q000628:therapy*; D001282:Atrial Flutter / Q000628:therapy*; D002304:Cardiac Pacing, Artificial; D004071:Digitalis Glycosides / Q000627:therapeutic use; D004554:Electric Countershock; D004617:Embolism / Q000517:prevention & control; D006801:Humans; D011342:Procainamide / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D014700:Verapamil / Q000627:therapeutic use
D000319:Adrenergic beta-Antagonists; D000925:Anticoagulants; D004071:Digitalis Glycosides; D014700:Verapamil; D011802:Quinidine; D011342:Procainamide